Home > Boards > Free Zone > Big Board Trading - Technical >

Biotech Ideas

RSS Feed
      Hide Sticky   Hide Intro
Moderator: gfp927z Assistants:
Search This Board: 
Last Post: 5/27/2020 1:10:48 PM - Followers: 2 - Board type: Free - Posts Today: 0

A board to discuss biotech ideas -


Aduro Biotech (ADRO) - Immunotherapy, cancer, autoimmune (213 - 33) (17 mil) -- (B) -- (255 mil) 
Chiasma (CHMA) - Acromegaly, transient permeability enhancer platform (92 - 2) ---- (B) -- (221 mil) 
ChemoCentryx (CCXI) - Inflammatory, autoimmune, cancer (72 - 21) (36 mil) -------- (B) -- (3.1 Bil)
Eagle Pharma (EGRX) - Critical care, oncolgy (109 - 42) (195 mil) ----------------------- (D-- (735 mil) 
Enanta (ENTA) - Infectious diseases, Hep C (373 - 10) (187 mil) -------------------------- (D) -- (1 Bil)
Kura Oncology (KURA) - Cancer (236 - 8) (n/a) ----------------------------------------------- (B) -- (639 mil)
Magenta Therapeutics (MGTA) - Autoimmune, MAB conjugates (145 - n/a) (n/a) --- (B) -- (349 mil)
Macrogenics (MGNX) - Cancer, MABs, conjugates (215 - 30) (64 mil) ------------------ (B) -- (1.2 Bil)
MEI Pharma (MEIP) - Cancer (200 - 0) (4 mil) -------------------------------------------------- (B) -- (246 mil)
Minerva Neurosciences (NERV) - Neuro, psych (45 - 0) (n/a) ----------------------------- (B) -- (321 mil)
Otonomy (OTIC) - Neurotology (ears) (60 - 33) (1 mil) ---------------------------------------- (B) -- (62 mil)
Pieris Pharma (PIRS) - Asthma, respiratory, inflam, cancer, kidney (104 - 16) (46 mil)(B) - (148 mil)
Synlogic (SYBX) - Metabolic, inflam, cancer (119 - 25) (2 mil) ------------------------------ (B) -- (75 mil)
Xenon Pharmaceuticals (XENE) - Neurological (141 - 16) (6 mil) ------------------------- (B) - (435 mil)


Acadia (ACAD) - Neurological, CNS (8 Bil) (697 - 10) (339 mil) -------------------------------------- (8 Bil)
Amgen (AMGN) - Blood cell stimulators, other ---------------------------------------------------------- (136 Bil)
Axsome Therapeutics (AXSM) - CNS disorders (220 - 20) (n/a) --------------------------------- (3.4 Bil)
Neurocrine Biosciences (NBIX) - Neurological, endocrine (670 - 503) (788 mil) --------------- (9 Bil)
Seattle Genetics (SGEN) - Cancer, autoimmune, armed MABs ----------------------------------- (24 Bil)


OTHER - 
***********
CytoDyn (CYDY) - Covid, HIV, Cancer (7 - 4) (n/a) --------------------------------------------------- (1.7 Bil)
Innovation Pharma (IPIX) - Cancer, inflam, antibiotics, acquired Polymedix, Cellceutix ---- (28 mil)


___________________________________________________________________
 

SPDR S&P Biotech ETF (XBI) (Exp - 0.35%, Assets - 3.5 Bil, Yld - 0.01%)

Name Symbol % Assets
Regeneron Pharmaceuticals Inc REGN 2.77%
Moderna Inc MRNA 2.65%
Gilead Sciences Inc GILD 2.43%
Vertex Pharmaceuticals Inc VRTX 2.32%
Biogen Inc BIIB 2.28%
United Therapeutics Corp UTHR 2.26%
Biomarin Pharmaceutical Inc BMRN 2.25%
Seattle Genetics Inc SGEN 2.16%
Exelixis Inc EXEL 2.06%
ACADIA Pharmaceuticals Inc ACAD 2.04%

__________________________________________________________________________

First Trust NYSE Arca Biotech Index (FBT) (Exp - 0.57%, Assets - 1.5 Bil, Yld - 0)

 

Name Symbol % Assets
Regeneron Pharmaceuticals Inc REGN 4.88%
Gilead Sciences Inc GILD 4.58%
Qiagen NV QGEN 4.48%
Biogen Inc BIIB 4.28%
Seattle Genetics Inc SGEN 4.08%
United Therapeutics Corp UTHR 3.93%
Vertex Pharmaceuticals Inc VRTX 3.89%
ACADIA Pharmaceuticals Inc ACAD 3.75%
Biomarin Pharmaceutical Inc BMRN 3.69%
Alnylam Pharmaceuticals Inc ALNY 3.53%

________________________________________________________________________
 

ARK Genomic Revolution ETF (ARKG) (Exp - 0.75%, Assets - 515 mil, Yld - 0)

Name Symbol % Assets
Invitae Corp NVTA 9.84%
CRISPR Therapeutics AG CRSP 9.34%
Illumina Inc ILMN 8.85%
Compugen Ltd CGEN 5.73%
Intellia Therapeutics Inc NTLA 5.62%
Iovance Biotherapeutics Inc IOVA 5.17%
Editas Medicine Inc EDIT 4.12%
Arcturus Therapeutics Holdings Inc ARCT 3.70%
Cellectis SA ADR CLLS.PA 3.47%
Guardant Health Inc GH 3.34%

_____________________________________________________________________________
 
PostSubject
#32   >>> Is Axsome Therapeutics a Buy? gfp927z 05/27/20 01:10:48 PM
#31   >>> Better Buy: Biogen vs. Axsome Therapeutics gfp927z 05/27/20 12:57:04 PM
#30   >>> Innovation Pharmaceuticals Receives Data from Public Health gfp927z 05/27/20 12:47:20 PM
#29   >>> What's Behind Axsome Therapeutics' Miracle Pipeline? gfp927z 05/21/20 05:33:33 PM
#28   >>> Innovation Pharmaceuticals’ Brilacidin Reduces Viral Titer of gfp927z 05/19/20 11:27:56 AM
#27   >>> 3 Biotech ETFs Up 10% Or More gfp927z 05/13/20 06:30:03 PM
#26   >>> Provention Bio, Inc. (PRVB), a clinical stage gfp927z 05/06/20 08:14:45 PM
#25   >>> Here's Why MacroGenics Stock Is Skyrocketing 171% Today gfp927z 05/06/20 04:23:23 PM
#24   >>> Cytokine Storms May Be Fueling Some COVID Deaths gfp927z 05/06/20 02:35:06 AM
#23   >>> Here's Why Axsome Therapeutics Rocketed 61.5% Higher gfp927z 05/06/20 02:03:08 AM
#22   >>> A human monoclonal antibody blocking SARS-CoV-2 infection gfp927z 05/05/20 02:08:28 PM
#21   >>> First Report of Human Monoclonal Antibody That gfp927z 05/05/20 01:55:36 PM
#20   >>> Defensin-mimetics as antibiotics, antifungals, and anti-inflammatorie gfp927z 05/05/20 01:22:59 PM
#19   >>> Inhibitory Effect of Innovation Pharmaceuticals’ Brilacidin on gfp927z 05/05/20 12:17:47 PM
#18   >>> CytoDyn down 9% as CEO moves to gfp927z 05/04/20 08:15:31 PM
#17   >>> US Biocontainment Laboratories gfp927z 05/04/20 05:43:08 PM
#16   #DDAmanda Chart on: $IPIX : Zardiw 05/04/20 09:06:15 AM
#15   >>> Innovation Pharmaceuticals Informed Next Phase of Brilacidin gfp927z 05/03/20 09:48:42 PM
#14   >>> Why Kura Oncology Is Skyrocketing Today gfp927z 04/28/20 05:12:08 PM
#13   >>> ChemoCentryx Reports Fourth Quarter and Full Year gfp927z 04/28/20 12:27:28 AM
#12   >>> Chiasma, Inc. (CHMA), a clinical-stage biopharmaceutical company, gfp927z 04/27/20 04:27:36 PM
#11   >>> MEI Pharma Set To Explode With Announcement gfp927z 04/27/20 04:12:31 PM
#10   >>> Axsome Therapeutics, Inc. (AXSM), a clinical stage gfp927z 04/27/20 02:29:18 PM
#9   >>> ChemoCentryx, Inc. (CCXI), a clinical-stage biopharmaceutical company gfp927z 04/27/20 02:25:06 PM
#8   >>> Drug maker ChemoCentryx shares rocket on blockbuster gfp927z 04/27/20 02:20:25 PM
#7   >>> Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint gfp927z 04/27/20 11:34:59 AM
#6   Migraine - Momentum Phase 3 - >>> Axsome gfp927z 04/24/20 04:13:14 PM
#5   AXS-07 - gfp927z 04/24/20 03:58:55 PM
#4   >>> Axsome Therapeutics Reports Fourth Quarter and Full gfp927z 04/24/20 01:01:44 PM
#3   >>> About AXS-07 (Migraine) - gfp927z 04/24/20 12:58:18 PM
#2   AXS-07 for Migraine - >>> Axsome Therapeutics Announces gfp927z 04/24/20 12:39:57 PM
#1   Axsome Therapeutics (AXSM) - gfp927z 04/23/20 02:46:46 PM
PostSubject